PHARMACOLOGICAL CORRECTION OF METABOLIC SYNDROME AND CHRONIC KIDNEY DISEASE
Aim. Optimization of pharmacotherapy of patients with metabolic syndrome and chronic kidney disease according to the nephroprotective properties of antihypertensive drugs.Methods. 81 patients (38 male, 43 female, age 29-79 years, mean age 53,4± 11,6 years) with metabolic syndrome and normal kidney f...
Saved in:
| Main Authors: | T. E. Morozova, E. M. Shilov, A. V. Beloborodova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
2010-06-01
|
| Series: | Сеченовский вестник |
| Subjects: | |
| Online Access: | https://www.sechenovmedj.com/jour/article/view/660 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methods of renal function assessment in arterial hypertension: the clinical value and practical implementation
by: Zh. D. Kobalava, et al.
Published: (2009-12-01) -
Renal pathology features in arterial hypertension patients with and without metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01) -
Risk Factors in Chronic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus Patients Attending a Tertiary Care Hospital in South Tamil Nadu, India: A Cross-sectional Study
by: S Priya, et al.
Published: (2024-12-01) -
Proaterogenic disorders of lipid and carbohydrate metabolism in chronic kidney disease nondiabetic origin
by: T. N. Solomenchuk, et al.
Published: (2013-06-01) -
Chronic Kidney Disease: Current State of the Problem
by: M. M. Batiushin
Published: (2020-12-01)